| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.50M | — |
| Operating expense | — | — |
| Net income | -24.28M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CRBU returned -10.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +4.4% |
| 1 year | -10.3% |
| 5 years | -93.9% |
| All-time high | $27.20 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CRBU would be worth today ›No. Caribou Biosciences, Inc. has not paid a dividend in the past 12 months.
Caribou Biosciences, Inc. stock trades on NASDAQ under the ticker symbol CRBU.
Caribou Biosciences, Inc. is part of the Healthcare sector.
Caribou Biosciences, Inc. has a market cap of 177.96M USD, based on the latest quote.
Caribou Biosciences, Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
